Nafamostat mesilate (FUT-175)
Nafamostat mesilate is a synthetic serine protease inhibitor, used as an anticoagulant during hemodialysis. Nafamostat mesylate blocks activation of SARS-CoV-2 and is investigated as a new treatment option for COVID-19. Nafamostat Mesilate attenuates inflammation and apoptosis.
| Catalog Number | S1386 |
| Molecular Formula | C19H17N5O2.2CH4O3S |
| CAS# | 82956-11-4 |
| Inchi | InChI=1S/C19H17N5O2.2CH4O3S/c20-17(21)14-2-1-13-10-16(8-5-12(13)9-14)26-18(25)11-3-6-15(7-4-11)24-19(22)23;2*1-5(2,3)4/h1-10H,(H3,20,21)(H4,22,23,24);2*1H3,(H,2,3,4) |
| Inchi Key | SRXKIZXIRHMPFW-UHFFFAOYSA-N |
| SMILES | CS(=O)(=O)O.CS(=O)(=O)O.C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N |
| Size | 10mg |
| Supplier Page | http://www.selleckchem.com/products/Nafamostat-mesylate.html |
| Additional Information | https://file.selleck.cn/downloads/struct/Nafamostat-mesylate-chemical-structure-S1386.gif |